Therefore, we hypothesized that ACSL1 regulates the p53/p21 signaling pathway by targeting SIRT1, thereby affecting the senescence, cell cycle and proliferation of CML cells. This evidence concerns the gene TP53 and chronic myelogenous leukemia, BCR-ABL1 positive.